Focus:
News
-
18 September 2019
Abbott’s paediatric heart devices secure CE-Mark
Abbott has received the European CE-Mark approval for its Masters HP mechanical heart valve and Amplatzer Piccolo Occluder device to treat babies and children with common congenital heart defects (CHD).
-
18 September 2019
Happify Health forms digital therapeutics alliance with Sanofi
Happify Health, a provider of mental health technology and digital therapeutics, has partnered with pharmaceutical giant Sanofi to offer prescription digital therapeutics for improving the mental health of multiple sclerosis...
-
18 September 2019
Zimmer Biomet’s JuggerStitch receives US clearance
Zimmer Biomet has received the US Food and Drug Administration (FDA) 510(k) clearance for the use of its JuggerStitch device in meniscal repair procedures.
-
17 September 2019
CMR Surgical raises £195m in Series C round
UK-based medical robotics company CMR Surgical has raised £195m in its Series C funding round, pushing the company value to over £1bn before the launch of its first product.
-
17 September 2019
Myriad to initiate UK study of Prolaris test in prostate cancer
Molecular diagnostics maker Myriad Genetics has partnered with Leeds Centre for Personalised Medicine and Health (LCPMH) in the UK to investigate the clinical utility of its Prolaris test in diagnosing...
-
17 September 2019
Siemens unveils new CT systems for radiation therapy planning
German medical technology firm Siemens Healthineers has unveiled two computed tomography (CT) systems to aid radiation therapy planning.
-
17 September 2019
Medtronic partners with Novo Nordisk on digital diabetes solutions
Medtronic has partnered with Novo Nordisk to offer digital solutions that will combine their respective technologies to help diabetic patients better manage their condition.
-
16 September 2019
Abbott and Sanofi partner to develop diabetes management tech
Abbott and Sanofi are partnering to integrate their glucose sensing and insulin delivery technologies, with ambitions to simplify how people with diabetes manage their condition.
-
16 September 2019
Abionic’s test detects sepsis within five minutes in study
Swiss diagnostic solutions developer Abionic has reported positive results from an observational study of Pancreatic Stone Protein (PSP) test for the detection of sepsis.
-
16 September 2019
FDA authorises Roche’s cobas pro solutions for diagnostic labs
Roche has received the US Food and Drug Administration (FDA) clearance for its cobas pro integrated solutions to support operations in diagnostic laboratories.
Close
Close
Close
Go Top
